| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine, Divisions of Endocrinology and Metabolism and Nuclear Medicine, and the Department of Surgery, University of Michigan Medical Center Ann Arbor, Michigan 48109
Address requests for reprints to: Aaron I. Vinik, M.D., 2922B/0331 Taubman Health Care Center, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109.
Alterations in cardiac sympathetic innervation may result in QT interval prolongation and predispose to sudden arrhythmias and death. Sudden cardiac death occurs in diabetic patients who have autonomic neuropathy, but the cause is uncertain. In 30 patients with insulin-dependent diabetes mellitus who had no evidence of ischemic heart disease, cardiac autonomic neuropathy, determined by clinical tests, was found in 17. The corrected QT interval (QTc), measured using Bazetts formula at rest and peak exercise, was prolonged (>440 msec) in 12 of these patients at rest and in 15 at peak exercise. Prolonged QTc intervals were found only in patients who had definite cardiac autonomic neuropathy. As a group, the QTc interval (mean ± SD) in the diabetic patients with cardiac autonomic neuropathy was prolonged compared to that in patients without cardiac autonomic neuropathy at rest (447 ± 28 vs. 405 ± 9 ms; P < 0.0001) and peak exercise (468 ± 23 vs. 402 ± 23 ms; P < 0.0001). There was a direct linear relationship between the extent of cardiac autonomic neuropathy and the QTc interval (r = 0.71; P < 0.001). One of the patients with cardiac autonomic neuropathy and prolonged QTC intervals had a nonuniform loss of adrenergic neurons in his heart demonstrated by meta-iodob-enzyl-guanidine scintigraphy, indicating sympathetic imbalance; he subsequently died unexpectedly. These data suggest that diabetic cardiac autonomic neuropathy may result in sympathetic imbalance and QTc interval prolongation, predisposing these patients to sudden arrhythmias and death.
* This work was supported by grants to the Clinical Research Center (5MO1-RR-00042-22) and the Michigan Diabetes Research and Training Center (AM-20572-07), and NIH Grant ROl-AM-21477.
Received September 18, 1986.
This article has been cited by other articles:
![]() |
J M Pappachan, J Sebastian, B C Bino, K Jayaprakash, K Vijayakumar, P Sujathan, and L A Adinegara Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis Postgrad. Med. J., April 1, 2008; 84(990): 205 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Whitsel, E. J. Boyko, P. M. Rautaharju, T. E. Raghunathan, D. Lin, R. M. Pearce, S. A. Weinmann, and D. S. Siscovick Electrocardiographic QT Interval Prolongation and Risk of Primary Cardiac Arrest in Diabetic Patients Diabetes Care, August 1, 2005; 28(8): 2045 - 2047. [Full Text] [PDF] |
||||
![]() |
B. E.K. Klein, R. Klein, P. E. McBride, S. E. Moss, R. J. Prineas, and J. O. Reinke Electrocardiographic Abnormalities in Individuals With Long-Duration Type 1 Diabetes Diabetes Care, January 1, 2005; 28(1): 145 - 147. [Full Text] [PDF] |
||||
![]() |
Y. Zhang, H. Han, J. Wang, H. Wang, B. Yang, and Z. Wang Impairment of Human Ether-a-Go-Go-related Gene (HERG) K+ Channel Function by Hypoglycemia and Hyperglycemia. SIMILAR PHENOTYPES BUT DIFFERENT MECHANISMS J. Biol. Chem., March 14, 2003; 278(12): 10417 - 10426. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Singh Diabetes, Heart Rate, and Mortality Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 117 - 129. [Abstract] [PDF] |
||||
![]() |
N. Takahashi, M. Nakagawa, T. Saikawa, T. Ooie, K. Yufu, S. Shigematsu, M. Hara, H. Sakino, I. Katsuragi, T. Okeda, et al. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients J. Am. Coll. Cardiol., July 1, 2001; 38(1): 232 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kornitzer Predictive value of electrocardiographic markers for autonomic nervous system dysfunction in healthy populations: more studies needed Eur. Heart J., January 2, 2001; 22(2): 109 - 112. [PDF] |
||||
![]() |
A. Gastaldelli, M. Emdin, F. Conforti, S. Camastra, and E. Ferrannini Insulin prolongs the QTc interval in humans Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2022 - R2025. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, R. B. Devereux, B. V. Howard, R. R. Fabsitz, E. T. Lee, and T. K. Welty Assessment of QT Interval and QT Dispersion for Prediction of All-Cause and Cardiovascular Mortality in American Indians : The Strong Heart Study Circulation, January 4, 2000; 101(1): 61 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Davey A new physiological method for heart rate correction of the QT interval Heart, August 1, 1999; 82(2): 183 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. HARATI Diabetic Peripheral Neuropathies Ann Intern Med, October 1, 1987; 107(4): 546 - 559. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |